Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#1031
Protagonist Therapeutics, Inc
92.080
0
+6.88%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+6.88%
Monthly Change
+11.68%
6 month change
+22.56%
Year Change
+22.56%
Previous Close
86.150
0
Open
92.210
0
Bid
Ask
Low
92.080
0
High
92.220
0
Volume
152
Markets
US Stock Market
Healthcare
PTGX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.81 M
48.41 M
51.28 M
58.27 M
61.38 M
63.81 M
—
Valuation ratios
Enterprise value
765.82 M
1.53 B
427 M
1.18 B
2.27 B
5.44 B
15.61 B
Price to earnings ratio
—
—
-4.15
-16.85
9.13
-42.6
197.31
Price to sales ratio
—
—
19.89
22.16
5.78
120.66
173.34
Price to cash flow ratio
—
—
4.89
18.93
13.64
96.28
256.13
Price to book ratio
—
—
2.45
3.95
3.72
9.03
13.23
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.2
0.36
0.51
0.22
0.37
0.19
0.19
Return on equity %
0.24
0.42
0.59
0.23
0.41
0.21
0.2
Return on invested capital %
881.2
2 568.99
5 504.26
6 840.28
655.36
311.93
459.71
Gross margin %
100
100
100
100
100
100
400
Operating margin %
72.17 K
460.01
494.24
156.09
58.2
343.63
2 488.48
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
73.99 K
458.94
479.26
131.59
63.34
282.83
2 099.78
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.84
7.74
7.8
16.71
12.48
12.71
59.98
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.08
0.09
0.2
0.79
0.07
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.03
—
—
—
—
—
—
Long term debt to total equity ratio
0.04
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.2
1.24
2.83
0.91
0.93
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.84
6.02
6.44
8.92
36.06
Net current asset value per share
—
—
4.96
6.26
9.09
9.09
37.39
Tangible book value per share
—
—
4.4
5.93
10.38
9.67
41.25
Working capital per share
—
—
4.32
5.89
8.36
8.37
34.85
Book value per share
—
—
4.4
5.93
10.38
9.67
41.25
News
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Protagonist Therapeutics director Williams sells $1.48 million in shares
Protagonist Therapeutics director sells $1.67 million in shares
Top Biotech Stocks to Watch in 2026, According to Truist
Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright
Protagonist Stock: Assessing The 2026 Upside For Icotrokinra And Rusfertide (PTGX)
Ali Asif, CFO of protagonist, sells $3.8m in PTGX stock
Protagonist Therapeutics CEO Patel sells $4m in shares
Protagonist Therapeutics chief medical officer sells $1.9m in shares
JPMorgan reiterates Overweight rating on Protagonist Therapeutics stock
Wednesday’s Insider Activity: Top Buys and Sells for January 21